MERRIMACK PHARMACEUTICALS INC Uncategorized Contracts & Agreements

17 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Section 382 Rights Agreement
MERRIMACK PHARMACEUTICALS INC
Biotechnology
2024
Description of the Registrants Securities Registered under Section 12 of the Exchange Act
MERRIMACK PHARMACEUTICALS INC
Biotechnology
2024
Amendment to Section 382 Rights Plan dated December 2, 2022
MERRIMACK PHARMACEUTICALS INC
Biotechnology
2022
Description of the Registrants Securities Registered under Section 12 of the Exchange Act
MERRIMACK PHARMACEUTICALS INC
Biotechnology
2022
Description of the Registrants Securities Registered under Section 12 of the Exchange Act
MERRIMACK PHARMACEUTICALS INC
Biotechnology
2021
Description of the Registrants Securities Registered under Section 12 of the Exchange Act
MERRIMACK PHARMACEUTICALS INC
Biotechnology
2020
Section 382 Rights Agreement, dated as of December 3, 2019, between Merrimack Pharmaceuticals, Inc. and Computershare Trust Company, N.A., as Rights Agent
MERRIMACK PHARMACEUTICALS INC
Biotechnology
DE
2019
ASSETPURCHASE AND SALE AGREEMENT between MERRIMACK PHARMACEUTICALS, INC., a Delaware Corporation; and IPSEN S.A., aSociété Anonyme; Dated as of January 7, 2017 Table of Contents
MERRIMACK PHARMACEUTICALS INC
Biotechnology
MA
2017
CONVERSION AGREEMENT
MERRIMACK PHARMACEUTICALS INC
Biotechnology
NY
2016
COLLATERAL AGREEMENT DATED AS OFDECEMBER 22, 2015 AMONG MERRIMACK PHARMACEUTICALS, INC., as Issuer, THE SUBSIDIARY PARTIESFROM TIME TO TIME PARTY HERETO U.S. BANK NATIONAL...
MERRIMACK PHARMACEUTICALS INC
Biotechnology
NY
2015
Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Double asterisks denote omissions.
MERRIMACK PHARMACEUTICALS INC
Biotechnology
2015
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
MERRIMACK PHARMACEUTICALS INC
Biotechnology
2014
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
MERRIMACK PHARMACEUTICALS INC
Biotechnology
DE
2014
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
MERRIMACK PHARMACEUTICALS INC
Biotechnology
DE
2014
Vest Date
MERRIMACK PHARMACEUTICALS INC
Biotechnology
DE
2012
Vest Date
MERRIMACK PHARMACEUTICALS INC
Biotechnology
DE
2012
Y (A-B)
MERRIMACK PHARMACEUTICALS INC
Biotechnology
CT
2011